Keros Therapeutics, Inc. Increase (Decrease) in Other Operating Assets
Keros Therapeutics, Inc. (KROS) reported Increase (Decrease) in Other Operating Assets of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-03
- Keros Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was $0.00.
- Keros Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $0.00.
- Keros Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Keros Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $0.00.
- Keros Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2025 was -$2.06M, a 51500.00% decline from fiscal 2024.
- Keros Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2024 was $4.00K, a 99.16% decline from fiscal 2023.
- Keros Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2023 was $478.00K, a 69.63% decline from fiscal 2022.
- Keros Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2022 was $1.57M.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $0.00 10-Q · filed 2026-08-03 | $0.00 derived: sum of 3 quarters · filed 2026-08-03 | $0.00 derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-05-14 | $0.00 derived: sum of 3 quarters · filed 2026-05-14 | -$463.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $0.00 derived: sum of 2 quarters · filed 2026-03-04 | -$463.00K derived: sum of 3 quarters · filed 2026-08-03 | -$2.06M 10-K · filed 2026-03-04 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$463.00K derived: sum of 2 quarters · filed 2026-08-03 | -$2.06M 10-Q · filed 2025-11-05 | -$1.59M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | -$463.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$2.06M 10-Q · filed 2026-08-03 | -$1.59M derived: sum of 3 quarters · filed 2026-08-03 | -$2.08M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | -$1.59M 10-Q · filed 2026-05-14 | -$1.12M derived: sum of 2 quarters · filed 2026-05-14 | -$1.61M derived: sum of 3 quarters · filed 2026-05-14 | -$1.59M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $469.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$22.00K derived: sum of 2 quarters · filed 2026-03-04 | $4.00K derived: sum of 3 quarters · filed 2026-03-04 | $4.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | -$491.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$465.00K derived: sum of 2 quarters · filed 2025-11-05 | -$465.00K 10-Q · filed 2025-11-05 | $13.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $26.00K 10-Q · filed 2025-08-06 | $504.00K derived: sum of 3 quarters · filed 2025-08-06 | $504.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-06 | $478.00K derived: sum of 2 quarters · filed 2025-05-06 | $478.00K derived: sum of 3 quarters · filed 2025-05-06 | |
| 2023-12-31 | $478.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $478.00K derived: sum of 2 quarters · filed 2025-02-26 | $478.00K 10-K · filed 2025-02-26 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-07 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $1.57M 10-K · filed 2025-02-26 | ||
| 2022-09-30 | $1.57M 10-Q · filed 2023-11-06 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |